Several brokerages have updated their recommendations and price targets on shares of Cascadian Therapeutics (NASDAQ: CASC) in the last few weeks:
Cascadian Therapeutics Inc. (NASDAQ:CASC) opened at 1.02 on Monday. Cascadian Therapeutics Inc. has a 1-year low of $0.82 and a 1-year high of $3.75. The firm has a 50-day moving average price of $1.15 and a 200-day moving average price of $1.16. The firm’s market capitalization is $138.02 million.